Exact Mass: 454.25799240000003
Exact Mass Matches: 454.25799240000003
Found 500 metabolites which its exact mass value is equals to given mass value 454.25799240000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Verapamil
Verapamil is only found in individuals that have used or taken this drug. Verapamil is a calcium channel blocker that is a class IV anti-arrhythmia agent. [PubChem]Verapamil inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thuis reducing heart rate and blood pressure. Verapamils mechanism of effect in cluster headache is thought to be linked to its calcium-channel blocker effect, but which channel subtypes are involved is presently not known. [PubChem] Calcium channel antagonists can be quite toxic. In the management of poisoning, early recognition is critical. Calcium channel antagonists are frequently prescribed, and the potential for serious morbidity and mortality with over dosage is significant. Ingestion of these agents should be suspected in any patient who presents in an overdose situation with unexplained hypotension and conduction abnormalities. The potential for toxicity should be noted in patients with underlying hepatic or renal dysfunction who are receiving therapeutic doses. (PMID 8213877). C - Cardiovascular system > C08 - Calcium channel blockers > C08D - Selective calcium channel blockers with direct cardiac effects > C08DA - Phenylalkylamine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker A calcium channel blocker that is a class IV anti-arrhythmia agent. -- Pubchem; COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents CONFIDENCE standard compound; INTERNAL_ID 8557 CONFIDENCE standard compound; INTERNAL_ID 2260 CONFIDENCE standard compound; INTERNAL_ID 4081 D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker KEIO_ID V021; [MS2] KO009311 Corona-virus KEIO_ID V021 Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Vistamycin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID R016
Withanolide B
Withanolide B is found in herbs and spices. Withanolide B is a constituent of the leaves of Lycium chinense (Chinese boxthorn) Withanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and anti-cancer effects[1][2][3]. Withanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and anti-cancer effects[1][2][3].
Macrocarpal C
Macrocarpal C is isolated from Eucalyptus globulus (Tasmanian blue gum). Isolated from Eucalyptus globulus (Tasmanian blue gum)
Euglobal VII
Euglobal VII is a constituent of Eucalyptus globulus (Tasmanian blue gum) Constituent of Eucalyptus globulus (Tasmanian blue gum).
Euglobal IVa
Euglobal IVb is a constituent of Eucalyptus globulus (Tasmanian blue gum)
Euglobal III
Euglobal III is a constituent of Eucalyptus globulus (Tasmanian blue gum)
Euglobal V
Euglobal V is a constituent of Eucalyptus globulus (Tasmanian blue gum) Constituent of Eucalyptus globulus (Tasmanian blue gum).
Methyl cellulose
C20H38O11 (454.24139979999995)
Methyl cellulose is a stabiliser, thickener and emulsifier for foodstuffs Different kinds of methyl cellulose can be prepared depending on the number of hydroxyl groups substituted. Cellulose is a polymer consisting of numerous linked glucose molecules, each of which exposes three hydroxyl groups. The Degree of Substitution (DS) of a given form of methyl cellulose is defined as the average number of substituted hydroxyl groups per glucose. The theoretical maximum is thus a DS of 3.0, however more typical values are 1.3 2.6. Methyl cellulose (or methylcellulose) is a chemical compound derived from cellulose. It is a hydrophilic white powder in pure form and dissolves in cold (but not in hot) water, forming a clear viscous solution or gel. It is sold under a variety of trade names and is used as a thickener and emulsifier in various food and cosmetic products, and also as a treatment of constipation. Like cellulose, it is not digestible, not toxic, and not allergenic A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AC - Bulk-forming laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative Stabiliser, thickener and emulsifier for foodstuffs
Ethyl cellulose
C20H38O11 (454.24139979999995)
Ethyl cellulose is a stabiliser and thickener for foods. Diluent in food marking inks. Indirect additive arising by migration from paper/paperboard packaging Ethyl cellulose is a derivative of cellulose in which some of the hydroxyl groups on the repeating glucose units are converted into ethyl ether groups. The number of ethyl groups can vary depending on the manufacture. Stabiliser and thickener for foods. Diluent in food marking inks. Indirect additive arising by migration from paper/paperboard packaging D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions D001697 - Biomedical and Dental Materials D002317 - Cardiovascular Agents
Lithocholic acid 3-sulfate
ribostamycin
DG(2:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0)
DG(2:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-2OH(5,6)/2:0/0:0)
DG(20:3(8Z,11Z,14Z)-2OH(5,6)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-2OH(5,6)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/20:3(8Z,11Z,14Z)-2OH(5,6))
DG(2:0/0:0/20:3(8Z,11Z,14Z)-2OH(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/2:0)
DG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
1-(4-O-beta-D-glucopyranosyl-3-methoxyphenyl)-3,5-dihydroxydecane
1-(4-o-beta-d-glucopyranosyl-3-methoxyphenyl)-3,5-dihydroxydecane is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 1-(4-o-beta-d-glucopyranosyl-3-methoxyphenyl)-3,5-dihydroxydecane can be found in ginger, which makes 1-(4-o-beta-d-glucopyranosyl-3-methoxyphenyl)-3,5-dihydroxydecane a potential biomarker for the consumption of this food product.
alpha-Guttiferin
Constituent of Gamboge the resinous exudation of Garcinia morella (batuan). alpha-Guttiferin is found in herbs and spices and fruits.
Verapamil
C - Cardiovascular system > C08 - Calcium channel blockers > C08D - Selective calcium channel blockers with direct cardiac effects > C08DA - Phenylalkylamine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 674 EAWAG_UCHEM_ID 674; CONFIDENCE standard compound D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(10R)-3-heptyl-8-methoxy-10-pentyl-10,11-dihydro-2H,5H-furan[3,2-f]pyran[5,6-c][1]benzopyran-2,5-dione|fordianin A
(3xi,4R)-4-hydroxy-3-isopropylpentyl beta-rutinoside|(4R)-4-hydroxy-3-(1-methylethyl)pentyl rutinoside
C20H38O11 (454.24139979999995)
(5alpha,17alphaOH,22R)-5,17-Dihydroxy-1-oxowitha-2,6,24-trienolide
24,25,26,27-tetranor-apotirucalla(-apoeupha)-7alpha-acetoxy-1,14,20(22)-trien-3-oxo-23-oic acid|azadironic acid
(3aS,5R,5aS,7R,8S,9R,9aS,9bR)-dodecahydro-3a,7,8,9b-tetrahydroxy-5,8-dimethyl-1-methylidenenaphtho[2,1-b]furan-9-yl decanoate|strobilol K
jaborosalactone L|jaborosalactone-L|jaboroslactone-L
(4beta,22R)-4,27-Dihydroxy-1-oxowitha-2,5,24-trienolide
(20R,22R)-14beta,20beta-dihydroxy-1-oxowitha-3,5,24-trienolide|withacoagulin F
(3-Acetylglyceryl)ester 鈥樎?ent-13S)-8,9-Dioxo-8,9-seco-15-labdanoic acid
(2S,5S,8R,9S,10R,13S)-2-hydroperoxy-13-O-arabinopyranosyl-3,14-clerodadiene
(22R)-7alpha,27-dihydroxy-1-oxowitha-2,5,24-trienolide
20,21,22,23-tetrahydro-23-oxoazadirone|chisocheton F
1-[3-(7-ethoxy-6-hydroxy-3,7-dimethyloct-2-enyl)-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
2,3,22beta-trihydroxy-24,29-dinor-1,3,5(10)-friedelatriene-6,21-dione|22beta-hydroxy-7,8 dihydro-6-oxotingenol
Cyclo(leucylprolylphenylalanylprolyl)
C25H34N4O4 (454.25799240000003)
10(14)-pseudoguaien-8alpha-(3-methylbutyryloxy)-11-O-beta-D-xylopyranoside|echusoside
(22R)-4beta,27-dihydroxy-1-oxo-witha-2,5,24-trienolide|4beta,27-dihydroxy-1-oxo-22R-witha-2,5,24-trienolide|5,6-deoxywithaferin A|5,6-desoxywithaferin A
Tenovin-6
Tenovin-6, an analog of Tenovin-1 (HY-13423), is an activator of p53 transcriptional activity. Tenovin-6 inhibits the protein deacetylase activities of purified human SIRT1, SIRT2, and SIRT3 with IC50s of 21 μM, 10 μM, and 67 μM, respectively. Tenovin-6 also inhibits dihydroorotate dehydrogenase (DHODH)[1][2].
Withanolide B
Withanolide B is a withanolide. Withanolide B is a natural product found in Withania somnifera, Withania coagulans, and Datura metel with data available. Withanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and anti-cancer effects[1][2][3]. Withanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and anti-cancer effects[1][2][3].
Chisocheton compound F
20,21,22,23-tetrahydro-23-oxoazadirone is a limonoid that is 20,21,22,23-tetrahydroazadirone substituted by an additional oxo group at position 23. It has been isolated from Azadirachta indica. It has a role as a metabolite and a plant metabolite. It is an acetate ester, a cyclic terpene ketone, a limonoid, a tetracyclic triterpenoid and a butan-4-olide. It is functionally related to an azadirone. 20,21,22,23-Tetrahydro-23-oxoazadirone is a natural product found in Azadirachta indica, Cedrela odorata, and other organisms with data available. A limonoid that is 20,21,22,23-tetrahydroazadirone substituted by an additional oxo group at position 23. It has been isolated from Azadirachta indica.
Verapamil
C - Cardiovascular system > C08 - Calcium channel blockers > C08D - Selective calcium channel blockers with direct cardiac effects > C08DA - Phenylalkylamine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS relative retention time with respect to 9-anthracene Carboxylic Acid is 0.907 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.908
Glu Ile Pro Pro
Glu Leu Pro Pro
Glu Pro Ile Pro
Glu Pro Leu Pro
Glu Pro Pro Ile
Glu Pro Pro Leu
Gly His Lys Asn
Gly His Asn Lys
Gly Lys His Asn
Gly Lys Asn His
Gly Asn His Lys
Gly Asn Lys His
His Gly Lys Asn
His Gly Asn Lys
His Ile Ser Val
His Ile Val Ser
His Lys Gly Asn
His Lys Asn Gly
His Leu Ser Val
His Leu Val Ser
His Asn Gly Lys
His Asn Lys Gly
His Ser Ile Val
His Ser Leu Val
His Ser Val Ile
His Ser Val Leu
His Thr Val Val
His Val Ile Ser
His Val Leu Ser
His Val Ser Ile
His Val Ser Leu
His Val Thr Val
His Val Val Thr
Ile Glu Pro Pro
Ile His Ser Val
Ile His Val Ser
Ile Pro Glu Pro
Ile Pro Pro Glu
Ile Ser His Val
Ile Ser Val His
Ile Val His Ser
Ile Val Ser His
Lys Gly His Asn
Lys Gly Asn His
Lys His Gly Asn
Lys His Asn Gly
Lys Asn Gly His
Lys Asn His Gly
Lys Asn Pro Pro
Lys Pro Asn Pro
Lys Pro Pro Asn
Leu Glu Pro Pro
Leu His Ser Val
Leu His Val Ser
Leu Pro Glu Pro
Leu Pro Pro Glu
Leu Ser His Val
Leu Ser Val His
Leu Val His Ser
Leu Val Ser His
Asn Gly His Lys
Asn Gly Lys His
Asn His Gly Lys
Asn His Lys Gly
Asn Lys Gly His
Asn Lys His Gly
Asn Lys Pro Pro
Asn Pro Lys Pro
Asn Pro Pro Lys
Pro Glu Ile Pro
Pro Glu Leu Pro
Pro Glu Pro Ile
Pro Glu Pro Leu
Pro Ile Glu Pro
Pro Ile Pro Glu
Pro Lys Asn Pro
Pro Lys Pro Asn
Pro Leu Glu Pro
Pro Leu Pro Glu
Pro Asn Lys Pro
Pro Asn Pro Lys
Pro Pro Glu Ile
Pro Pro Glu Leu
Pro Pro Ile Glu
Pro Pro Lys Asn
Pro Pro Leu Glu
Pro Pro Asn Lys
Ser His Ile Val
Ser His Leu Val
Ser His Val Ile
Ser His Val Leu
Ser Ile His Val
Ser Ile Val His
Ser Leu His Val
Ser Leu Val His
Ser Val His Ile
Ser Val His Leu
Ser Val Ile His
Ser Val Leu His
Thr His Val Val
Thr Val His Val
Thr Val Val His
Val His Ile Ser
Val His Leu Ser
Val His Ser Ile
Val His Ser Leu
Val His Thr Val
Val His Val Thr
Val Ile His Ser
Val Ile Ser His
Val Leu His Ser
Val Leu Ser His
Val Ser His Ile
Val Ser His Leu
Val Ser Ile His
Val Ser Leu His
Val Thr His Val
Val Thr Val His
Val Val His Thr
Val Val Thr His
PG(14:1(9Z)/0:0)
C20H39O9P (454.23315740000004)
methyl cellulose
C20H38O11 (454.24139979999995)
A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AC - Bulk-forming laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative
Withanolide B
Withanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and anti-cancer effects[1][2][3]. Withanolide B is an active component of W. somnifera Dunal. Withanolide B promotes osteogenic differentiation of hBMSCs via ERK1/2 and Wnt/β-catenin signaling pathways. Withanolide B exhibits neuroprotective, anti-arthritic, anti-aging and anti-cancer effects[1][2][3].
Euglobal IVa
Euglobal VII
Euglobal V
Euglobal III
Ethocel
C20H38O11 (454.24139979999995)
D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions D001697 - Biomedical and Dental Materials D002317 - Cardiovascular Agents
macrocarpal C
1-(furan-2-yl)-3-[2-[[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]benzimidazol-1-yl]propan-1-one
C28H30N4O2 (454.23686399999997)
Octimibate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
siramesine
C30H31FN2O (454.24202879999996)
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene
dexverapamil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(R)-octan-2-yl 4-((4-(hexyloxy)benzoyl)oxy)benzoate
TRIISOPROPYL((4-((4-((TRIMETHYLSILYL)ETHYNYL)PHENYL)ETHYNYL)PHENYL)ETHYNYL)SILANE
(S)-Octan-2-yl 4-((4-(hexyloxy)benzoyl)oxy)benzoate
Octyl4-O-(b-D-galactopyranosyl)-b-D-glucopyranoside
C20H38O11 (454.24139979999995)
4-methylumbelliferyl phosphate, bis(cyclohexylammonium) salt
C22H35N2O6P (454.22326200000003)
Benzyl 3-isobutyrloxy-1-isopropyl-2,2-dimethylpropyl phthalate
Ohcos
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)-N-[(1R,2R)-1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-1-hydroxy-3-methylbutan-2-yl]acetamide
2-[3,4-Dihydroxy-2-hydroxymethyl-5-(2-hydroxy-nonyl)-tetrahydro-furan-2-yloxy]-6-hydroxymethyl-tetra hydro-pyran-3,4,5-triol
C20H38O11 (454.24139979999995)
20-hydroxy-leukotriene E4(1-)
C23H36NO6S- (454.22632160000006)
Conjugate base of 20-hydroxy-leukotriene E4.
octyl 6-O-beta-D-galactofuranosyl-alpha-D-glucopyranoside
C20H38O11 (454.24139979999995)
A disaccharide derivative that is the octyl glycoside of the disaccharide beta-D-galactofuranosyl-(1->6)-alpha-D-glucose.
phosphono [(2E,7R,11S)-3,7,11,15-tetramethylhexadeca-2,14-dienyl] hydrogen phosphate
[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] tetradec-9-enoate
C20H39O9P (454.23315740000004)
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (E)-tetradec-11-enoate
C20H39O9P (454.23315740000004)
1-(4-O-beta-D-glucopyranosyl-3-methoxyphenyl)-3,5-dihydroxydecane
1,2-Dicaproyl-sn-glycero-3-phosphocholine
C20H41NO8P+ (454.25696560000006)
A 1,2-diacyl-sn-glycero-3-phosphocholine(1+) that is the dicaproyl diester of phosphatidiylcholine.
(3R,3aS,7R,7aS)-3-[4-[4-(dimethylamino)phenyl]-2-fluorophenyl]-7-methyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one
C30H31FN2O (454.24202879999996)
3-cyclohexyl-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-1-[2-(1-pyrrolidinyl)ethyl]urea
C25H34N4O4 (454.25799240000003)
(3S,5aS,8aR,9aS)-7,7,8,8-tetramethyl-5a-nitrospiro[1,8-dihydropyrano[2,3-g]indole-3,7-2,3,4,5,6,8a,9,9a-octahydro-1H-cyclopenta[f]indolizin-4-ium]-2,9-dione
1-[(2-Methoxyphenyl)-[1-(2-phenylethyl)-5-tetrazolyl]methyl]-4-phenylpiperazine
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
N-benzyloxycarbonylaminoethyl-4,6-dideoxy-4-(3-hydroxy-3-methylbutanamido)-2-O-methyl-beta-D-glucopyranoside
5alpha-Androstane-3alpha-glcosyl-17beta-diol
A steroid saponin that is 5alpha-androstane-3alpha,17beta-diol attached to a alpha-D-glucopyranosyl residue at position 3 via a glycosidic linkage.
[(1R)-7-methoxy-9-methyl-1-[[4-(2-pyridinyl)phenyl]methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C28H30N4O2 (454.23686399999997)
[(1S)-7-methoxy-9-methyl-1-[[4-(2-pyridinyl)phenyl]methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C28H30N4O2 (454.23686399999997)
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-phenylurea
C25H34N4O4 (454.25799240000003)
1-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-phenylurea
C25H34N4O4 (454.25799240000003)
1-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-phenylurea
C25H34N4O4 (454.25799240000003)
1-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-phenylurea
C25H34N4O4 (454.25799240000003)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridin-4-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridin-4-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridin-4-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
ethyl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(phenylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-methoxyphenyl)methyl]acetamide
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
(1S)-2-(2-cyclopropyl-1-oxoethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propan-2-yl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
C25H34N4O4 (454.25799240000003)
2-[[(2S)-2,3-di(hexanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H41NO8P+ (454.25696560000006)
1-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-phenylurea
C25H34N4O4 (454.25799240000003)
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-phenylurea
C25H34N4O4 (454.25799240000003)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridin-4-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridin-4-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridin-4-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridin-4-ylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C25H34N4O4 (454.25799240000003)
ethyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2S,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
Octyl 6-O-[(4xi)-D-xylo-hexofuranosyl]-alpha-D-glucopyranoside
C20H38O11 (454.24139979999995)
(5E)-5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-(1H-pyridin-4-ylidene)-1H-imidazol-4-ylidene]-N-oxido-2,3-dihydroinden-1-amine
N,N,N-Trimethyl-2-[[2,3-bis(hexanoyloxy)propoxy]phosphonyloxy]ethanaminium
C20H41NO8P+ (454.25696560000006)
2,3-dihydroxypropyl [2-hydroxy-3-[(Z)-pentadec-9-enoxy]propyl] hydrogen phosphate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tetradec-9-enoate
C20H39O9P (454.23315740000004)
alpha-D-Glucopyranoside, 2,3,4,6-tetra-O-methyl-alpha-D-glucopyranosyl 2,3,4,6-tetra-O-methyl-
C20H38O11 (454.24139979999995)
2,2,3,3,4,4,6,6-Octa-ortho-[D3]methyl-trehalose-D24
C20H38O11 (454.24139979999995)
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
(2S,3R,4S,5S,6S)-5-amino-2-(aminomethyl)-6-[(1S,2S,3R,4S,6R)-4,6-diamino-2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
2-[(3-Butanoyloxy-2-octanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H41NO8P+ (454.25696560000006)
2-[(3-Acetyloxy-2-decanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H41NO8P+ (454.25696560000006)
2-[(2-Heptanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H41NO8P+ (454.25696560000006)
2-[Hydroxy-(2-nonanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
C20H41NO8P+ (454.25696560000006)
ribostamycin
An amino cyclitol glycoside that is 4,6-diaminocyclohexane-1,2,3-triol having a 2,6-diamino-2,6-dideoxy-alpha-D-glucosyl residue attached at position 1 and a beta-D-ribosyl residue attached at position 2. It is an antibiotic produced by Streptomyces ribosidificus (formerly S. thermoflavus). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Ethyl cellulose
C20H38O11 (454.24139979999995)
D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions D001697 - Biomedical and Dental Materials D002317 - Cardiovascular Agents
1-(9Z-tetradecenoyl)-glycero-3-phospho-(1-sn-glycerol)
C20H39O9P (454.23315740000004)
15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
8-(benzoyloxy)-6-(hydroxymethyl)-2,13-dimethyl-12-oxotetracyclo[11.2.1.0¹,¹⁰.0²,⁷]hexadecane-6-carboxylic acid
7a,9-dihydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,9,10,11,11b,12-hexahydro-6h-2,5-dioxatetraphen-1-one
5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-ol
C26H34N2O5 (454.24675940000003)
(1r,3br,4s,5r,5as,9ar,9br,11as)-1-(4,5-dihydrofuran-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
2-{7-[6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-4-methylhept-3-en-1-yl}-2,6-dimethylchromene-5,8-dione
6-(1-{5a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
3b,6,6,9a,11a-pentamethyl-7-oxo-1-(5-oxooxolan-3-yl)-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
2-[(4e,8e)-10-(5-hydroxy-2-methoxy-3-methylphenyl)-4,8-dimethyl-6-oxodeca-4,8-dien-1-yl]-2,6,6-trimethylpyran-3-one
(1s,2r,7s,9r,11s,12s,15r,16s)-15-[(1s)-1-[(2s)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
5-heptyl-12-methoxy-15-pentyl-3,9,14-trioxatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-1(10),2(7),5,11,13(17)-pentaene-4,8-dione
2-[(2e)-4-[(1s,4'r,4as,7as)-4'-methoxy-4a,5',5',7a-tetramethyl-6,7-dihydro-5h-spiro[cyclopenta[c]pyran-1,2'-oxolan]-3-yl]-3-methylbut-2-en-1-yl]-6-methylcyclohexa-2,5-diene-1,4-dione
(1s,4r,6s,7e,11r,12s)-14,16-dihydroxy-1,5,5,8-tetramethyl-12-(2-methylpropyl)-19-oxatetracyclo[9.8.0.0⁴,⁶.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-15,17-dicarbaldehyde
6-(1-{3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
(6r)-6-[(1s)-1-[(1r,3as,3bs,6s,9ar,9bs,11as)-6-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
(1s,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2s)-2-methyl-5-oxooxolan-2-yl]-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthrene-3,4,7,10-tetrone
(1s,3br,4r,5ar,9ar,9br,11as)-3b,6,6,9a,11a-pentamethyl-7-oxo-1-[(3s)-5-oxooxolan-3-yl]-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(2r,4s,4ar,6ar,6br,12br,14as,14bs)-4,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,6b,7,13,14,14b-decahydropicene-3,8-dione
(1s,2s,4r,5s,10r,11s,14r,15r,18s)-15-[(1r)-1-[(2s,3s)-3-hydroxy-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one
(2s,3r,4r,4as,7r,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (2e,4s)-4-hydroxydec-2-enoate
(6r)-6-[(1r)-1-[(1s,3ar,3br,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
8-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-4-(hydroxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one
3-benzyl-5,14-dihydroxy-12-(2-methylpropyl)-1,4,10,13-tetraazatricyclo[13.3.0.0⁶,¹⁰]octadeca-4,13-diene-2,11-dione
C25H34N4O4 (454.25799240000003)
(1s,2r,4r,7e,11s,19s)-15,17-dihydroxy-3,3,7,11-tetramethyl-19-(2-methylpropyl)-12-oxatetracyclo[9.8.0.0²,⁴.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-14,16-dicarbaldehyde
(1s,2r,7s,9r,11s,12s,15r,16s)-15-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
(1s,2r,4s,7e,11s,19r)-15,17-dihydroxy-3,3,7,11-tetramethyl-19-(2-methylpropyl)-12-oxatetracyclo[9.8.0.0²,⁴.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-14,16-dicarbaldehyde
3-benzyl-5,14-dihydroxy-12-(sec-butyl)-1,4,10,13-tetraazatricyclo[13.3.0.0⁶,¹⁰]octadeca-4,13-diene-2,11-dione
C25H34N4O4 (454.25799240000003)
(3e,9r)-9-hydroxy-1-(6-methoxy-2,8-dimethylchromen-2-yl)-4,8,12-trimethyltrideca-3,11-diene-2,10-dione
14,16-dihydroxy-3,3,7,11-tetramethyl-15-(3-methylbutanoyl)-19-oxatetracyclo[9.8.0.0²,⁴.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-17-carbaldehyde
13-benzyl-11-hydroxy-3,6,8-trimethyl-3h,4h,5h,6h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclohexadecane-1,9,14-trione
C26H34N2O5 (454.24675940000003)
5-[(1s)-1-[(1as,4ar,7r,7as,7bs)-1,1,7-trimethyl-4-methylidene-octahydrocyclopropa[e]azulen-7-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde
15-[1-(3-hydroxy-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one
1-(2-chloro-2,4b,8,8,10a-pentamethyl-1,4a,5,6,7,8a,9,10-octahydrophenanthrene-1-carbonyloxy)-3-hydroxypropan-2-yl acetate
(1s,5s)-8-[(9ar,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-(hydroxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one
(6r)-6-[(1r)-1-[(1s,3ar,3br,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
3-hydroxy-4,5,5,6',10',12'-hexamethyl-6'-(3-oxobutyl)-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2'(7'),3',8'-trien-5'-one
(1s,3'r,5'r,12s,13r,16s,18r,20s,21r)-5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-ol
C26H34N2O5 (454.24675940000003)
1,2,3-trimethyl (1r,2s)-1-{[(1s,4ar,5r,8as)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}propane-1,2,3-tricarboxylate
(1s,3br,4r,5ar,9ar,9br,11s,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate
[(1s,2r,4as,8s,8ar)-8-(acetyloxy)-5-(3,5-dihydroxy-3-methylpentyl)-2-hydroxy-1,4a,6-trimethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]methyl acetate
3-(16-carboxy-4,8,12,16-tetramethylhexadeca-2,6,10,15-tetraen-1-yl)-4-hydroxybenzoic acid
(3s,4r,12s,13r,17r,20r)-18-[(2s,3r,4s)-3,4-dimethyl-5-oxooxolan-2-yl]-17-hydroxy-4,17-dimethyl-19,21-dioxahexacyclo[11.6.1.1¹,¹⁵.0³,¹².0⁴,⁹.0¹⁶,²⁰]henicosa-7,9-dien-5-one
(2r,3r,4r,5s,6r)-5-amino-2-(aminomethyl)-6-{[(1r,2r,3s,4r,6s)-4,6-diamino-2-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol
(1r,2s,4s,4as,5s,5's,6r,8as)-6-(acetyloxy)-5'-(2-hydroxyethyl)-5-(hydroxymethyl)-2,5,5',8a-tetramethyl-3-oxo-hexahydrospiro[naphthalene-1,2'-oxolan]-4-yl acetate
ethyl (1r,2r,5s,10s,11r,13s,16s)-6,6,10,13,16-pentamethyl-7,15-dioxo-12,20-dioxahexacyclo[9.7.2.1²,¹⁶.0¹,¹³.0²,¹¹.0⁵,¹⁰]henicosa-8,17-diene-18-carboxylate
(4r,6s,7e,11r)-14,16-dihydroxy-1,5,5,8-tetramethyl-12-(2-methylpropyl)-19-oxatetracyclo[9.8.0.0⁴,⁶.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-15,17-dicarbaldehyde
2-[(1r,2r,3r,4as,5s,5's,6r,8as)-5-[(acetyloxy)methyl]-3,6-dihydroxy-2,5,5',8a-tetramethyl-4-oxo-hexahydrospiro[naphthalene-1,2'-oxolan]-5'-yl]ethyl acetate
(1r,2s,4s,7e,11s)-14,16-dihydroxy-3,3,7,11-tetramethyl-15-(3-methylbutanoyl)-19-oxatetracyclo[9.8.0.0²,⁴.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-17-carbaldehyde
(5ar,7as,9s,11ar,11br)-7a,9-dihydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,9,10,11,11b,12-hexahydro-6h-2,5-dioxatetraphen-1-one
(1s,2s,4s,5r,10r,11s,14r,15r,18s)-15-[(1s)-1-[(2s)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5-hydroxy-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one
(2e)-3-[(1s,3br,4r,5ar,9ar,9br,11as)-4-(acetyloxy)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]but-2-enoic acid
(1s,9r,10r,11r,12r,14r,17s)-5,7-dihydroxy-10,13,13,17-tetramethyl-9-(2-methylpropyl)-2-oxapentacyclo[8.7.2.0¹,¹¹.0³,⁸.0¹²,¹⁴]nonadeca-3,5,7-triene-4,6-dicarbaldehyde
15-{1-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
5,7-dihydroxy-10,13,13,17-tetramethyl-9-(2-methylpropyl)-2-oxapentacyclo[8.7.2.0¹,¹¹.0³,⁸.0¹²,¹⁴]nonadeca-3,5,7-triene-4,6-dicarbaldehyde
(1r,3br,5r,5ar,9ar,9br,11as)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(1s,2r,7s,9r,11s,12s,15s,16s)-15-[(1r)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-15-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
(3r,6r,13s,18as)-13-benzyl-11-hydroxy-3,6,8-trimethyl-3h,4h,5h,6h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclohexadecane-1,9,14-trione
C26H34N2O5 (454.24675940000003)
(1r,3'r,6r,7's,8'r)-10',12'-dihydroxy-3-isopropyl-6,7'-dimethyl-8'-(2-methylpropyl)-2'-oxaspiro[cyclohexane-1,4'-tricyclo[7.4.0.0³,⁷]tridecane]-1'(13'),2,9',11'-tetraene-11',13'-dicarbaldehyde
(1s,2s,4s,5r,10r,11r,14r,15r,18s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5-hydroxy-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one
(1r,2s,4r,7e,11r,19s)-15,17-dihydroxy-3,3,7,11-tetramethyl-19-(2-methylpropyl)-12-oxatetracyclo[9.8.0.0²,⁴.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-14,16-dicarbaldehyde
(1s,2r,6s,7r,9r,11s,12s,15r,16s)-15-[(1s)-1-[(2s)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
10',12'-dihydroxy-3-isopropyl-6,7'-dimethyl-8'-(2-methylpropyl)-2'-oxaspiro[cyclohexane-1,4'-tricyclo[7.4.0.0³,⁷]tridecane]-1'(13'),2,9',11'-tetraene-11',13'-dicarbaldehyde
methyl (1r,3br,4s,5r,5ar,6r,9ar,9bs,11as)-1-(furan-3-yl)-4,5-dihydroxy-3b,6,9a,11a-tetramethyl-9-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthrene-6-carboxylate
20-acetyl-10-hydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3(12),4(9),10-triene-8,19-dione
(1s,4ar,4br,6as,12as,12br,14ar)-10-(acetyloxy)-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-1-carboxylic acid
(1s,2s,4r,10r,11s,14s,15r,18s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-15-hydroxy-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-5-en-9-one
(6s)-6-[(1s)-1-[(1r,3as,3bs,5r,9ar,9bs,11as)-5-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
(2s)-2-[(4e,8e)-10-(5-hydroxy-2-methoxy-3-methylphenyl)-4,8-dimethyl-6-oxodeca-4,8-dien-1-yl]-2,6,6-trimethylpyran-3-one
(1r,5r,8r)-8-[(1s,2r,5s,7s,8r,10s,11s,14r,15s)-8-hydroxy-2,15-dimethyl-3-oxopentacyclo[8.7.0.0²,⁷.0⁵,⁷.0¹¹,¹⁵]heptadecan-14-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
3-{10,14-dimethyl-13-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-4-oxatetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadeca-1(16),8-dien-2-yl}propanoic acid
(1s,4r,6r,7e,11r,12s)-14,16-dihydroxy-1,5,5,8-tetramethyl-12-(2-methylpropyl)-19-oxatetracyclo[9.8.0.0⁴,⁶.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-15,17-dicarbaldehyde
(2s,3r,4r,4as,7s,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (2e,4s)-4-hydroxydec-2-enoate
(1s,4r,5s,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-(hydroxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one
3-[4-(acetyloxy)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]but-2-enoic acid
(1s,4r,6s,7e,11r,12r)-14,16-dihydroxy-1,5,5,8-tetramethyl-12-(2-methylpropyl)-19-oxatetracyclo[9.8.0.0⁴,⁶.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-15,17-dicarbaldehyde
3-[(2e,6e,10e,15z)-16-carboxy-4,8,12,16-tetramethylhexadeca-2,6,10,15-tetraen-1-yl]-4-hydroxybenzoic acid
(5ar,7as,9r,11ar,11br)-7a,9-dihydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,9,10,11,11b,12-hexahydro-6h-2,5-dioxatetraphen-1-one
3a,6,6,9a,11a-pentamethyl-1-(2-methyl-5-oxooxolan-2-yl)-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthrene-3,4,7,10-tetrone
(1s,2s,7r,9s,11s,12s,15s,16s)-15-[(1r)-1-[(2s)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
(3s,6r,12s,15s)-3-benzyl-5,14-dihydroxy-12-(2-methylpropyl)-1,4,10,13-tetraazatricyclo[13.3.0.0⁶,¹⁰]octadeca-4,13-diene-2,11-dione
C25H34N4O4 (454.25799240000003)
3-(2-chloro-2,4b,8,8,10a-pentamethyl-1,4a,5,6,7,8a,9,10-octahydrophenanthrene-1-carbonyloxy)-2-hydroxypropyl acetate
8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl 4-hydroxydec-2-enoate
(3e,8s,9r)-9-hydroxy-1-[(2s)-6-methoxy-2,8-dimethylchromen-2-yl]-4,8,12-trimethyltrideca-3,11-diene-2,10-dione
15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-15-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
2-[10-(5-hydroxy-2-methoxy-3-methylphenyl)-4,8-dimethyl-6-oxodeca-4,8-dien-1-yl]-2,6,6-trimethylpyran-3-one
1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate
(1r,3br,4s,5r,5ar,9ar,9br,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
9-hydroxy-1-(6-methoxy-2,8-dimethylchromen-2-yl)-4,8,12-trimethyltrideca-3,11-diene-2,10-dione
(2s)-1-[(1s,2s,4as,4br,8ar,10as)-2-chloro-2,4b,8,8,10a-pentamethyl-1,4a,5,6,7,8a,9,10-octahydrophenanthrene-1-carbonyloxy]-3-hydroxypropan-2-yl acetate
methyl 2-(2-acetyl-7-hydroxy-4b,6a,9,10b,12a-pentamethyl-8-oxo-5,6,7,9,10,10a,11,12-octahydrochrysen-1-ylidene)acetate
6-(1-{3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
2-[3,6,9,12-tetrahydroxy-8-(c-hydroxycarbonimidoylmethyl)-11-(2-methylpropyl)-5-(sec-butyl)-1,4,7,10-tetraazacyclododeca-1(12),3,6,9-tetraen-2-yl]ethanimidic acid
10-(acetyloxy)-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-1-carboxylic acid
4,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,6b,7,13,14,14b-decahydropicene-3,8-dione
(3s,4r,12s,13r,17r,20r)-18-[(2s,3r,4s)-3,4-dimethyl-5-oxooxolan-2-yl]-17-hydroxy-4,17-dimethyl-19,21-dioxahexacyclo[11.6.1.1¹,¹⁵.0³,¹².0⁴,⁹.0¹⁶,²⁰]henicosa-6,9-dien-5-one
6-(1-{6-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
(15r)-5-heptyl-12-methoxy-15-pentyl-3,9,14-trioxatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-1(10),2(7),5,11,13(17)-pentaene-4,8-dione
6-(1-{3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
(1r,3br,4s,5r,5ar,9ar,9br,11as)-1-(4,5-dihydrofuran-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(1's,2s,2's,3r,4s,4's,7's,8's,9'r,10's,13's,14'r)-7'-hydroxy-3,4,8',10',14'-pentamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosane]-15',18'-diene-5,17'-dione
2-[(2s,5s,8s,11s)-3,6,9,12-tetrahydroxy-8-(c-hydroxycarbonimidoylmethyl)-11-(2-methylpropyl)-5-(sec-butyl)-1,4,7,10-tetraazacyclododeca-1(12),3,6,9-tetraen-2-yl]ethanimidic acid
(1'r,2s,3r,4s,6'r,10'r,11'r,12's)-3-hydroxy-4,5,5,6',10',12'-hexamethyl-6'-(3-oxobutyl)-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2'(7'),3',8'-trien-5'-one
(6r)-6-[(1r)-1-[(1s,3ar,3br,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
15,17-dihydroxy-3,3,7,11-tetramethyl-19-(2-methylpropyl)-12-oxatetracyclo[9.8.0.0²,⁴.0¹³,¹⁸]nonadeca-7,13,15,17-tetraene-14,16-dicarbaldehyde
6-(1-{5-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one
(2s)-3-[(1s,2s,4as,4br,8ar,10as)-2-chloro-2,4b,8,8,10a-pentamethyl-1,4a,5,6,7,8a,9,10-octahydrophenanthrene-1-carbonyloxy]-2-hydroxypropyl acetate
methyl 2-[(1z,4bs,6ar,7s,9r,10as,10bs,12ar)-2-acetyl-7-hydroxy-4b,6a,9,10b,12a-pentamethyl-8-oxo-5,6,7,9,10,10a,11,12-octahydrochrysen-1-ylidene]acetate
(1s,2r,6s,7r,9r,11s,12s,15r,16s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
(6r,6ar,6br,8ar,9s,11r,12as,12bs,14ar)-3,6,9-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-6,6a,7,8,9,11,12,12a,13,14-decahydropicene-2,10-dione
(6r)-6-[(1r)-1-[(1s,3as,3br,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
2,4,6-trihydroxy-5-(3-methyl-1-{1,1,7-trimethyl-4-methylidene-octahydrocyclopropa[e]azulen-7-yl}butyl)benzene-1,3-dicarbaldehyde
(3s,6s,12s,15s)-3-benzyl-5,14-dihydroxy-12-(2-methylpropyl)-1,4,10,13-tetraazatricyclo[13.3.0.0⁶,¹⁰]octadeca-4,13-diene-2,11-dione
C25H34N4O4 (454.25799240000003)